Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders

BACKGROUND: Congenital myasthenic syndromes (CMS) are a group of inherited neuromuscular transmission disorders causing fatiguable muscle weakness. ADRB2 agonists have been observed to provide therapeutic benefit where destabilisation of NMJ structures is part of the underlying pathology, such as in...

Descripción completa

Detalles Bibliográficos
Autores principales: Clausen, Lisa, Cossins, Judith, Beeson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2018
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004912/
https://www.ncbi.nlm.nih.gov/pubmed/29865088
http://dx.doi.org/10.3233/JND-170293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004912/
https://www.ncbi.nlm.nih.gov/pubmed/29865088
http://dx.doi.org/10.3233/JND-170293

Ejemplares similares